Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

Rita Anzalone, Felicia Farina, Giampiero La Rocca, Antonino Di Stefano, Pantaleo Giannuzzi, Melania Lo Iacono, Tiziana Loria

Research output: Contribution to journalArticle

124 Citations (Scopus)

Fingerprint Dive into the research topics of 'Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences